1. Home
  2. IPDN vs LGVN Comparison

IPDN vs LGVN Comparison

Compare IPDN & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Professional Diversity Network Inc.

IPDN

Professional Diversity Network Inc.

N/A

Current Price

$0.13

Market Cap

6.6M

Sector

Technology

ML Signal

N/A

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$6.58

Market Cap

21.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPDN
LGVN
Founded
2003
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
21.4M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
IPDN
LGVN
Price
$0.13
$6.58
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
2.1M
469.5K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.76
EPS
N/A
N/A
Revenue
$22,054,219.00
$709,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.48
52 Week High
$5.07
$7.30

Technical Indicators

Market Signals
Indicator
IPDN
LGVN
Relative Strength Index (RSI) 29.01 86.91
Support Level N/A $0.61
Resistance Level $0.45 $7.30
Average True Range (ATR) 0.02 0.33
MACD 0.01 0.36
Stochastic Oscillator 20.26 90.24

Price Performance

Historical Comparison
IPDN
LGVN

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc provides access to networking, training, educational, and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates the majority of its revenue from the TalentAlly Network Segment.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: